AM-Pharma racks up $176m
AM-Pharma B.V., a Dutch developer of treatment for acute kidney injury, has raised additional funding of $52 million, increasing its recent total tally to $176 million.
AM-Pharma B.V., a Dutch developer of treatment for acute kidney injury, has raised additional funding of $52 million, increasing its recent total tally to $176 million.
Copyright PEI Media
Not for publication, email or dissemination